(Q34619806)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21099364%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Transcriptional and post-transcriptional mechanisms of BAFF-receptor dysregulation in human B lineage malignancies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21099364%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21099364%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

3

Diane F Jelinek

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21099364%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

2

Renee C Tschumper

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21099364%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

15 December 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21099364%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

number of pages

9

1 reference

inferred from page(s)

published in

Cell Cycle

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21099364%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21099364%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21099364%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

4884-4892

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21099364%20AND%20SRC:MED&resulttype=core&format=json

The structure of the TNFRSF13C promoter enables differential expression of BAFF-R during B cell ontogeny and terminal differentiation.

16 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047811

A functional receptor for B-cell-activating factor is expressed on human acute lymphoblastic leukemias

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047811

Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047811

Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047811

Increased serum BAFF (B-cell activating factor of the TNF family) level is a peculiar feature associated with familial chronic lymphocytic leukemia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047811

BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047811

Role of BAFF and APRIL in human B-cell chronic lymphocytic leukaemia.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047811

B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047811

Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047811

Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047811

Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047811

Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047811

Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047811

The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome

7 July 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.9.24.14156

Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.9.24.14156

Systemic activation of the immune system induces aberrant BAFF and APRIL expression in B cells in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.9.24.14156

Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.9.24.14156

BAFF and APRIL expression in B-cell chronic lymphocytic leukemia: correlation with biological and clinical features.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.9.24.14156

APRIL but not BLyS serum levels are increased in chronic lymphocytic leukemia: prognostic relevance of APRIL for survival

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.9.24.14156

BLyS and BLyS receptor expression in non-Hodgkin's lymphoma

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21099364

12 December 2020

inferred from PubMed ID database lookup

Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survival

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21099364

12 December 2020

inferred from PubMed ID database lookup

Anti-BR3 antibodies: a new class of B-cell immunotherapy combining cellular depletion and survival blockade

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21099364

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.4161/CC.9.24.14156

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21099364%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21099364%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

PubMed publication ID

21099364

1 reference